| Code | CSB-RA011046MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to QX-006N, targeting IFNAR1 (Interferon Alpha and Beta Receptor Subunit 1). IFNAR1 is a critical component of the type I interferon receptor complex, forming a heterodimer with IFNAR2 to mediate cellular responses to interferon-alpha and interferon-beta signaling. This receptor plays essential roles in antiviral immunity, immune cell activation, and regulation of inflammatory responses. Dysregulation of IFNAR1 signaling has been implicated in various pathological conditions, including autoimmune diseases such as systemic lupus erythematosus, viral infections, and certain malignancies where aberrant interferon signaling contributes to disease progression or therapeutic resistance.
QX-006N serves as the reference antibody for this biosimilar product, originally developed for investigating IFNAR1-mediated signaling pathways and their functional consequences. This antibody is valuable for researchers studying type I interferon biology, examining receptor expression patterns, investigating immune response mechanisms, and exploring therapeutic strategies targeting interferon signaling in autoimmune disorders and cancer. The biosimilar format provides a cost-effective alternative for laboratory investigations requiring IFNAR1-specific detection and functional studies.
There are currently no reviews for this product.